MML Investors Services
LUCD icon

MML Investors Services’s Lucid Diagnostics LUCD Stock Holding History

MML Investors Services’s Portfolio LUCD Stock Details LUCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$57.5K Hold
50,000
– – ﹤0.01% 2930
2025
Q4 		$54.5K Hold
50,000
– – ﹤0.01% 2972
2025
Q3 		$50.5K Hold
50,000
– – ﹤0.01% 2863
2025
Q2 		$58K Buy
+50,000
New +$64.6K ﹤0.01% 2782

Other funds holding LUCD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

MML Investors Services's LUCD Position: Q1 2026 in Review

MML Investors Services held its Lucid Diagnostics (LUCD) position steady in Q1 2026 at 50,000 shares worth $57.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2930.

MML Investors Services first reported a position in LUCD in Q2 2025 and has held it in 4 quarters since. The position peaked at $58K in Q2 2025. 103 funds tracked by Wall St. Rank hold LUCD as of Q1 2026.

  • MML Investors Services held 50,000 shares of Lucid Diagnostics worth $57.5K as of Q1 2026.
  • MML Investors Services left its Lucid Diagnostics share count unchanged in Q1 2026.
  • Lucid Diagnostics made up ﹤0.01% of MML Investors Services's portfolio in Q1 2026, its #2930 holding.
  • MML Investors Services first reported a position in Lucid Diagnostics in Q2 2025 and has held it in 4 quarters since.
  • MML Investors Services's Lucid Diagnostics position peaked at $58K in Q2 2025.
  • 103 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q1 2026.

Based on MML Investors Services's 13F filing for Q1 2026, filed 4 May 2026.